The major evidence supporting the above-described mechanism includes 10 types of evidence supporting the nitric oxide/peroxynitrite theory of MCS (Pall
and Satterlee 2001); 10 "remarkable similarities" between neural sensitization and MCS (Ashford and Miller 1998); and five types of evidence suggesting NMDA hyperactivity in MCS (Pall
is the leader in membrane technology solutions and provides water treatment systems for more than 150 large and small municipalities and industrial customers worldwide.
eBDS uses a novel approach to detection by measuring oxygen consumption as the marker for bacteria.
UltiKleen(TM) Excellar ER and Ultipleat(R) SP DR Filters establish new performance benchmarks in the marketplace," says Steve Chisolm, President of Pall
As the first mixed-mode sorbents of this kind, HEA HyperCel and PPA HyperCel are poised to transform the way process chromatographers purify proteins," says Ken Frank, President of Pall
Filter Harvest System can be used as a closed system that adheres to Good Manufacturing Practice (cGMP), furthering the ability to comply with increasingly stringent regulations for safe, reproducible and efficacious cell products.
Our agreement with ViaCell is another milestone in Pall
's development and customization of tools to help make cell therapy routine, safe and simple," says Judy Angelbeck, PhD, Senior Vice President, Pall
Specifically, Entegris charges that a fluid separation device manufactured and marketed by Pall
as the PhotoKleen(TM) EZD-3 Filter Assembly infringes a patent owned by Entegris covering technology used for point-of-use photochemical dispense and filtration in semiconductor manufacturing.
Corporation (NYSE: PLL) introduces six new technologies at INTERPHEX2006 aimed at helping this converging marketplace bridge the gap between R&D and full-scale production.
Corporation (NYSE: PLL), global leaders and pioneers in point-of-use filtration for hospitals, today introduced the home version of their hospital shower filter, the Pall
-Aquasafe(TM) Water Filter for HomeCare Applications.
Corporation (NYSE: PLL) announced today that it was awarded a new long-term agreement with the English National Blood Service (NBS) to provide blood collection systems incorporating its proprietary filtration technology.
The first tap filter that reduces patient exposure to waterborne pathogens for up to 14 days was launched today in Europe by Pall
Corporation (NYSE: PLL).
NAMES LISA MCDERMOTT CHIEF FINANCIAL OFFICER AND TREASURER
Corporation's (NYSE: PLL) breathing system filters for anesthesia and respiratory care combine these stringent requirements to provide an effective barrier against viral and bacterial contaminants, and were specifically recommended by international health authorities.
A newly published study in the December issue of Transfusion shows a Pall
Corporation (NYSE: PLL) filtration technology is effective in removing prions from blood.